ACCF/ASE/ACEP/AHA/ASNC/SCAI/SCCT/SCMR 2008 Appropriateness Criteria for Stress Echocardiography⁎⁎Developed in accordance with the principles and methodology outlined by ACCF: Patel MR, Spertus JA, Brindis RG, Hendel RC, Douglas PS, Peterson ED, Wolk MJ, Allen JM, Raskin IE. ACCF proposed method for evaluating the appropriateness of cardiovascular imaging. J Am Coll Cardiol 2005;46:1606–13

Autor: Terry Golash, Roger D. Des Prez, David Porembka, Linda D. Gillam, Frederick A. Masoudi, Bijoy Khandheria, Susan E. Wiegers, John A. Spertus, Manesh R. Patel, L. Samuel Wann, Michael J. Wolk, Eric D. Peterson, Robert C. Hendel, William G. Kussmaul, Paul H. Mayo, Loren F. Hiratzka, Joseph M. Allen, Michael Blaivas, Ralph G. Brindis, Raymond F. Stainback, Pamela S. Douglas, JoAnn Lindenfeld, Neil J. Weissman, Arthur J. Labovitz

Publikováno v: Journal of the American College of Cardiology. 51:1127-1147

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80d6a8a20724a67632a312ca27bfe63b
https://doi.org/10.1016/j.jacc.2007.12.005

Stressor-Induced Reduction in Cognitive Behavior is Associated with Impaired Colonic Mucus Layer Integrity and is Dependent Upon the LPS-Binding Protein Receptor CD14

Autor: Jaggers RM, DiSabato DJ, Loman BR, Kontic D, Spencer KD, Allen JM, Godbout JP, Quan N, Gur TL, Bailey MT

Publikováno v: Journal of Inflammation Research, Vol Volume 15, Pp 1617-1635 (2022)

Robert M Jaggers,1 Damon J DiSabato,2,3 Brett R Loman,1 Danica Kontic,1 Kyle D Spencer,1,4,5 Jacob M Allen,1 Jonathan P Godbout,2,3 Ning Quan,6 Tamar L Gur,2,7 Michael T Bailey1,2,8 1Center for Microbial Pathogenesis, Abigail Wexner Research Institut

Externí odkaz: https://doaj.org/article/ad84557ce6d54b9bb86ae2c2c0d459c6

Eighteen-Month Hybrid Closed-Loop Use in Very Young Children With Type 1 Diabetes: A Single-Arm Multicenter Trial.

Autor: Ware J; Institute of Metabolic Science-Metabolic Research Laboratories, University of Cambridge, Cambridge, U.K.; Department of Paediatrics, University of Cambridge, Cambridge, U.K., Allen JM; Institute of Metabolic Science-Metabolic Research Laboratories, University of Cambridge, Cambridge, U.K.; Department of Paediatrics, University of Cambridge, Cambridge, U.K., Boughton CK; Institute of Metabolic Science-Metabolic Research Laboratories, University of Cambridge, Cambridge, U.K.; Wolfson Diabetes and Endocrine Clinic, Cambridge University Hospitals NHS Foundation Trust, Cambridge, U.K., Wilinska ME; Institute of Metabolic Science-Metabolic Research Laboratories, University of Cambridge, Cambridge, U.K.; Department of Paediatrics, University of Cambridge, Cambridge, U.K., Hartnell S; Wolfson Diabetes and Endocrine Clinic, Cambridge University Hospitals NHS Foundation Trust, Cambridge, U.K., Thankamony A; Department of Paediatrics, University of Cambridge, Cambridge, U.K., de Beaufort C; Diabetes & Endocrine Care Clinique Pédiatrique, Clinique Pédiatrique, Centre Hospitalier de Luxembourg, Luxembourg City, Luxembourg.; Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-Belval, Luxembourg.; Department of Paediatric Endocrinology, Universitair Ziekenhuis-Vrije Universiteit Brussels, Brussels, Belgium., Campbell FM; Department of Paediatric Diabetes, Leeds Children's Hospital, Leeds, U.K., Fröhlich-Reiterer E; Department of Pediatric and Adolescent Medicine, Medical University of Graz, Graz, Austria., Fritsch M; Department of Pediatric and Adolescent Medicine, Medical University of Graz, Graz, Austria., Hofer SE; Department of Pediatrics I, Medical University of Innsbruck, Innsbruck, Austria., Kapellen TM; Hospital for Children and Adolescents, University of Leipzig, Leipzig, Germany., Rami-Merhar B; Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria., Tauschmann M; Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria., Hovorka R; Institute of Metabolic Science-Metabolic Research Laboratories, University of Cambridge, Cambridge, U.K.; Department of Paediatrics, University of Cambridge, Cambridge, U.K.

Publikováno v: Diabetes care [Diabetes Care] 2024 Dec 01; Vol. 47 (12), pp. 2189-2195.

Social determinants of health and newer glucose-lowering drugs adoption among US Medicare beneficiaries with type 2 diabetes.

Autor: Chen WH; Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville., Li Y; Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville., Chen A; Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville., Allen JM; Department of Pharmacotherapy & Translational Research, College of Pharmacy, University of Florida, Orlando., Guo Y; Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville.; Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville.; Center for Drug Evaluation and Safety (CoDES), College of Pharmacy, University of Florida, Gainesville., Bilello L; Department of Surgery, University of Florida College of Medicine-Jacksonville., Smith SM; Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville.; Center for Drug Evaluation and Safety (CoDES), College of Pharmacy, University of Florida, Gainesville.; Center for Integrative Cardiovascular and Metabolic Disease, University of Florida, Gainesville., Yang L; Department of Pharmacy and Therapeutics, University of Pittsburgh, Pittsburgh, PA., Goodin AJ; Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville.; Center for Drug Evaluation and Safety (CoDES), College of Pharmacy, University of Florida, Gainesville., Bian J; Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville., Guo J; Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville.; Center for Drug Evaluation and Safety (CoDES), College of Pharmacy, University of Florida, Gainesville.; Center for Integrative Cardiovascular and Metabolic Disease, University of Florida, Gainesville.

Publikováno v: Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2024 Nov; Vol. 30 (11), pp. 1298-1307.

Impact of Ultra-Rapid Insulin on Boost and Ease-Off in the Cambridge Hybrid Closed-Loop System for Individuals With Type 1 Diabetes.

Autor: Royston C; Metabolic Research Laboratories, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK., Boughton C; Metabolic Research Laboratories, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.; Wolfson Diabetes and Endocrine Clinic, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Nwokolo M; Royal Free London NHS Foundation Trust, London, UK., Lakshman R; Metabolic Research Laboratories, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK., Hartnell S; Wolfson Diabetes and Endocrine Clinic, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Wilinska ME; Metabolic Research Laboratories, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.; Department of Paediatrics, University of Cambridge, Cambridge, UK., Ware J; Metabolic Research Laboratories, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.; Department of Paediatrics, University of Cambridge, Cambridge, UK., Allen JM; Metabolic Research Laboratories, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.; Department of Paediatrics, University of Cambridge, Cambridge, UK., Thabit H; Diabetes, Endocrinology and Metabolism Centre, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, UK., Mader JK; Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Bally L; Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Inselspital, Bern University Hospital, Bern, Switzerland., Leelarathna L; Diabetes, Endocrinology and Metabolism Centre, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, UK.; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK., Evans ML; Metabolic Research Laboratories, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.; Wolfson Diabetes and Endocrine Clinic, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Hovorka R; Metabolic Research Laboratories, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.; Department of Paediatrics, University of Cambridge, Cambridge, UK.

Publikováno v: Journal of diabetes science and technology [J Diabetes Sci Technol] 2024 Oct 18, pp. 19322968241289963. Date of Electronic Publication: 2024 Oct 18.